Posted on Nov 16, 2021
Pfizer agrees to license generic versions of its COVID-19 pill — in some countries
591
17
3
9
9
0
https://www.npr.org/2021/11/16/ [login to see] /pfizer-generic-paxlovid-deal-countries
Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from generic versions of its new COVID-19 pill. The agreement covers 95 nations, but it omits some hard-hit countries.
Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from generic versions of its new COVID-19 pill. The agreement covers 95 nations, but it omits some hard-hit countries.
Pfizer agrees to license generic versions of its COVID-19 pill — in some countries
Posted from npr.org
Drugs
Pharmaceuticals
Medical
Health
Edited >1 y ago
Posted >1 y ago
Responses: 3
3
3
0
PO1 William "Chip" Nagel This article makes a good point this pandemic needs to be attacked in all countries with all the tools we have at our disposal.
(3)
(0)
3
3
0
2
2
0
PO1 William "Chip" Nagel
..."The Pfizer antiviral pill is aided by co-administering a low dose of ritonavir, a drug used in HIV/AIDS treatment regimens. Ritonavir helps protease inhibitors like the Pfizer drug persist longer in the human body, making them more effective in fighting a virus.
Noting that ritonavir's patent has lapsed and the new Pfizer drug does not yet have a patent, Doctors Without Borders urged drugmakers in countries that are excluded by the deal to explore producing the generic medicine themselves.
"The world knows by now that access to COVID-19 medical tools needs to be guaranteed for everyone, everywhere if we really want to control this pandemic," Hu said."
..."The Pfizer antiviral pill is aided by co-administering a low dose of ritonavir, a drug used in HIV/AIDS treatment regimens. Ritonavir helps protease inhibitors like the Pfizer drug persist longer in the human body, making them more effective in fighting a virus.
Noting that ritonavir's patent has lapsed and the new Pfizer drug does not yet have a patent, Doctors Without Borders urged drugmakers in countries that are excluded by the deal to explore producing the generic medicine themselves.
"The world knows by now that access to COVID-19 medical tools needs to be guaranteed for everyone, everywhere if we really want to control this pandemic," Hu said."
(2)
(0)
Read This Next
Continue with Facebook 
Continue with Google